Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List
ACR Urges Commercial Payers to Provide Relief from Prior Authorizations, Practice Disruptions
Are Your Patients at Risk? Advocacy Matters
New D.C. Office Strengthens ACR Advocacy Efforts
ACR Leverages AMA Representation to Advance Rheumatology Issues
1 Person Can Make a Difference: The Importance of Advocacy
A Farewell Message from Outgoing Government Affairs Committee Chair Angus Worthing, MD, FACR, FACP
Making Rheumatologists’ Voices Count: A Conversation with Blair Solow, MD, Incoming Government Affairs Committee Chair
Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members
- 1
- 2
- 3
- …
- 25
- Next Page »